Two Sigma Advisers’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.14M Sell
896,576
-136,700
-13% -$783K 0.01% 729
2025
Q1
$8.43M Buy
1,033,276
+921,300
+823% +$7.52M 0.02% 592
2024
Q4
$1.05M Buy
111,976
+52,000
+87% +$490K ﹤0.01% 1432
2024
Q3
$641K Sell
59,976
-23,700
-28% -$253K ﹤0.01% 1604
2024
Q2
$830K Buy
83,676
+59,100
+240% +$586K ﹤0.01% 1649
2024
Q1
$290K Buy
+24,576
New +$290K ﹤0.01% 2081
2023
Q3
Sell
-235,676
Closed -$2.96M 2448
2023
Q2
$2.96M Sell
235,676
-201,000
-46% -$2.52M 0.01% 999
2023
Q1
$4.84M Sell
436,676
-82,200
-16% -$912K 0.01% 823
2022
Q4
$6.34M Sell
518,876
-209,500
-29% -$2.56M 0.02% 681
2022
Q3
$7.6M Buy
728,376
+112,000
+18% +$1.17M 0.02% 574
2022
Q2
$6.62M Sell
616,376
-15,200
-2% -$163K 0.02% 649
2022
Q1
$5.98M Sell
631,576
-224,000
-26% -$2.12M 0.02% 726
2021
Q4
$9.88M Buy
855,576
+503,500
+143% +$5.82M 0.02% 504
2021
Q3
$3.36M Sell
352,076
-659,400
-65% -$6.3M 0.01% 976
2021
Q2
$9.75M Sell
1,011,476
-542,300
-35% -$5.23M 0.03% 575
2021
Q1
$15.4M Buy
1,553,776
+507,600
+49% +$5.01M 0.04% 430
2020
Q4
$24.2M Buy
1,046,176
+688,200
+192% +$15.9M 0.06% 294
2020
Q3
$5.06M Buy
357,976
+214,100
+149% +$3.02M 0.01% 766
2020
Q2
$2.17M Buy
143,876
+122,976
+588% +$1.85M 0.01% 1164
2020
Q1
$193K Sell
20,900
-30,476
-59% -$281K ﹤0.01% 2178
2019
Q4
$500K Buy
+51,376
New +$500K ﹤0.01% 1875
2018
Q2
Sell
-16,000
Closed -$241K 2407
2018
Q1
$241K Sell
16,000
-1,200
-7% -$18.1K ﹤0.01% 2090
2017
Q4
$248K Buy
17,200
+1,800
+12% +$26K ﹤0.01% 2018
2017
Q3
$232K Buy
+15,400
New +$232K ﹤0.01% 2011
2016
Q1
Sell
-10,500
Closed -$102K 2065
2015
Q4
$102K Buy
+10,500
New +$102K ﹤0.01% 1772
2015
Q1
Sell
-207,673
Closed -$1.73M 1975
2014
Q4
$1.73M Sell
207,673
-1,400
-0.7% -$11.6K 0.01% 825
2014
Q3
$1.24M Buy
209,073
+194,100
+1,296% +$1.15M 0.01% 848
2014
Q2
$50K Buy
+14,973
New +$50K ﹤0.01% 1859